TCL Archive Commentary: NCI’s Budge Proposal ForFY2001 Offers A Blueprint for Research November 26, 1999
TCL Archive Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival January 31, 2014
TCL Archive Conversation With The Cancer Letter: Seffrin To Retire After Restructuring ACS January 24, 2014